Plasma and peritoneal fluid levels of CA 125 in women with endometriosis
- 1 December 1988
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 159 (6), 1526-1531
- https://doi.org/10.1016/0002-9378(88)90588-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgeryFertility and Sterility, 1988
- Serum CA-125 antigen levels increase during mensesAmerican Journal of Obstetrics and Gynecology, 1987
- The use of CA-125 in the diagnosis and management of endometriosisFertility and Sterility, 1986
- CA-125 levels in endometriosisFertility and Sterility, 1986
- Serum levels of CA-125 in patients with endometriosis: a preliminary reportFertility and Sterility, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Estrogenic and antiestrogenic effects of danazol administration in studies of estradiol receptor bindingAmerican Journal of Obstetrics and Gynecology, 1981
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formationAmerican Journal of Obstetrics and Gynecology, 1980